ENTITY
Akeso

Akeso (9926 HK)

368
Analysis
Health Care • China
Akeso is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative antibody drugs. It develops treatments for major diseases such as cancer, autoimmune diseases, inflammation, and metabolic diseases, with key products including cadonilimab, ivonescimab, and penpulimab. The company was founded in 2012 and is headquartered in Zhongshan, Guangdong, China.
more
•25 May 2026 10:00

HSCEI June 2026 Index Rebalance: Post-Announcement Positioning

HSCEI June 2026 post-announcement cycle is underway. Both ADDs posted negative pre-announcement returns. DELETE's post-announcement gap is the key...

Logo
156 Views
Share
•24 May 2026 10:10

HK Short Interest Weekly: Tencent, Yofc, Midea, AIA, Weichai Power, Time Interconnect Technology

We analyzed the latest HK SFC report for aggregate short position as of May 15th and highlight short interest changes in Tencent (700 HK), Yofc...

Logo
129 Views
Share
bullish•Wuxi Biologics
•22 May 2026 10:45

HSCEI May 2026 Index Review Forecast

HSCEI May 2026 rebalance announcement due after market close today: a good time to revisit our review forecast as the decision approaches.

Logo
416 Views
Share
•11 May 2026 17:23

Quiddity Leaderboard HSCEI Jun26: Announcement Next Week; US$196mn One-Way

From 3rd April 2026 close to 8th May 2026 close, the pair suggested in the previous insight would have generated an average return of approximately...

Share
•03 May 2026 10:10

HK Short Interest Weekly: Hua Hong Semiconductor, Kuaishou, CCB, ICBC, Techtronic, Zijin Gold Intl

We analyzed the latest HK SFC report for aggregate short position as of Apr 24th and highlight short interest changes in Hua Hong Semiconductor,...

Logo
264 Views
Share
x